stella
beta
Severe Bullous Drug Eruption and Filgrastim — Stella
Recruiting
Back to Rare Diseases trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
France
Département d'Anesthésie-Réanimation , Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon
Reference center for toxic bullous dermatoses and severe drug eruptions, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon
Service de Médecine Interne, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon
View full record on ClinicalTrials.gov